Scripta Insights, an organization that develops pharmacy navigation answers for self-insured employers, well being plans and contributors, is coming into right into a strategic partnership with RxSaveCard, which gives pharmacy get advantages cost-containment and fee choices.
The partnership goals to lend a hand self-insured employers satisfy their fiduciary tasks and cut back prescription drug prices by means of offering contributors with get right of entry to to inexpensive medicine choices, whether or not coated by means of their well being plan or by way of cash-pay choices.
In a observation, Scripta defined that it is going to combine RxSaveCard into its Rx Navigation platform, which the corporate says will get advantages purchasers who’ve the totally custom designed resolution in position.
For contributors, it goals to lend a hand them save on high-cost distinctiveness medication, together with GLP-1s.
For self-insured employers, the function is to scale back plan spend by means of keeping off conventional pharmacy get advantages supervisor (PBM) markups.
Moreover, Scripta will steer contributors to probably the most cost-effective medicine choices to be had.
That might imply a coated drug thru their well being plan, changing to a more cost effective selection or the usage of a coins pay supply like RxSaveCard.
Scripta said that the RxSaveCard additionally allows plan sponsors to supply low- or no-cost drugs to contributors with out requiring a transfer to a brand new PBM.
Moreover, employers fund a pay as you go virtual card each month that covers all or a part of the focused drug prices.
Participants will be capable of use the cardboard at over 65,000 pharmacies, together with Mark Cuban Value Plus Medicine and Lilly Direct, with the employer-funded quantity carried out mechanically at checkout.
In keeping with Scripta, contributors will be capable of seek for RxSaveCard discounted costs and pharmacy choices and get right of entry to their playing cards immediately within the Scripta member app. Scripta may even supply purchasers with detailed reporting on their financial savings.
“RxSaveCard stocks our dedication to innovating the standard pharmacy advantages style and placing sufferers again in keep an eye on in their prescription alternatives,” Eric Levin, CEO of Scripta Insights, mentioned in a observation.
“By way of integrating RxSaveCard’s national cut price community into our Scripta Financial savings Mapper, we’re making it even more straightforward for contributors to check all their choices, together with new coins pay choices, and lower your expenses on their prescriptions.”
THE LARGER TREND
In Might, Scripta Insights introduced its GLP-1 Navigator, a device within the Scripta member app that gives sufferers with details about GLP-1 drugs in a centralized information.
Up to date weekly, Scripta’s GLP-1 Navigator is helping contributors perceive their choices and the trade-offs, without reference to whether or not their plan covers GLP-1s.
In 2024, Scripta Insights introduced it raised $17 million in Sequence B investment, led by means of Aquiline, bringing its general investment to $42 million on the time.
Contour Challenge Companions, Eastside Companions and ReMY Buyers participated within the spherical.
In 2023, Scripta Insights collaborated with Mark Cuban Value Plus Drug Corporate.
In a observation, the corporate mentioned the connection furthered Scripta’s project to get contributors the proper meds at the most efficient worth.
In 2024, RxSaveCard raised $1.7 million in seed investment to power expansion and make bigger client get right of entry to to inexpensive drugs.
In keeping with BusinessWire, the spherical used to be led by means of Disbursed Ventures, with participation from trade insiders.
